Heart & cardiometabolic news, in plain English.
We follow the journals, trials and news our team reads every week — and rewrite each headline into a short, plain-English summary. Every item links back to the original source so you can read the full piece if you want.
[Comment] Tailoring levels of evidence in trials comparing common treatments
Doctors often have several good treatment options to choose from, but sometimes those treatments have only been tested against a placebo or dummy treatment, not directly against each other. This means it's not always clear which option works best for a particular patient. This matters for anyone facing a choice between established treatments, as it highlights a gap in the evidence used to guide those decisions. The practical message is that more head-to-head studies comparing real treatment options would help doctors and patients make better-informed choices together.
[The Lancet Commissions] The Lancet Commission on 21st century global threats to health
A major new report has looked at the big-picture threats facing health around the world in the years ahead, from pandemics and conflict to climate change and new technology like artificial intelligence. It's a reminder that unexpected events can change things quickly, as we've all seen with COVID-19 in recent years. This is really aimed at governments and health organisations rather than individuals, but the key message is that better planning and preparation now can help protect everyone's health in the future. For you personally, it doesn't change any advice about managing your own heart health today.
Glycosylated Fibronectin Compared With sFlt-1/PlGF Ratio for Preeclampsia Assessment
Researchers compared two blood tests that help doctors work out whether a pregnant woman with suspected pre-eclampsia is likely to need to give birth soon for her safety. One test, called GlyFn, uses a simple finger-prick sample and can be done quickly at the bedside, while the other involves a standard laboratory blood test. The study found that the finger-prick test was just as good at picking up women who went on to need an early birth because of pre-eclampsia. This matters most to pregnant women being monitored for pre-eclampsia, as a quicker, simpler test could mean faster answers and less waiting for results during an anxious time.
Aldosterone-Producing Lesions Harboring ATP1A1 and ATP2B3 Mutations: An International Multicenter Study
Hypertension, Ahead of Print. BACKGROUND:Somatic aldosterone-driver mutations are identified in >90% of patients with primary aldosteronism undergoing adrenalectomy, and they display distinct demographic clustering.ATP1A1andATP2B3mutations, encoding the Na+/K+ATPase α1 subunit and the Ca2+ATPase 3, respectively, are relatively rare and are often grouped asATPasemutations. Differences in their c
[Comment] 21st century global threats to health are not what you think
A major new report has looked ahead to the year 2100 to work out which health threats will cause the most harm to people around the world, and the findings may surprise you. The idea is to help governments plan properly for the future, rather than just reacting to whatever crisis is in the news, so that resources go where they'll do the most good over the long run. For anyone interested in heart health, this is a reminder that the biggest dangers to our wellbeing often build up quietly over decades, which is exactly why staying on top of your own risk factors early, rather than waiting for a crisis, remains one of the most sensible things you can do.
[Series] Governing the digital determinants of health for children and young people: a global public health imperative
Researchers are calling for a fresh approach to how digital technology, like social media and apps, affects the health of children and young people. Rather than focusing on individual device use or blaming families for screen time, the suggestion is that governments and regulators should look at the bigger picture, how these technologies are designed and run, since this shapes health risks for whole populations. This matters most for parents, policymakers and anyone concerned about young people's wellbeing in a digital world. The practical takeaway is that tackling these issues may need coordinated policy action rather than relying on individuals to manage the risks alone.
Summaries are AI-assisted rewrites of publicly-available news, intended for patients. They are not medical advice — for anything about your own care, please speak to your consultant or GP. Original articles are the sole property of their publishers.